DMEPOS Webinar

DMEPOS – CMS Compliance and Requirements Updates: Audio Version of the Webinar

Rachel V. Rose, JD, MBA, principal with Rachel V. Rose – Attorney at Law, P.L.L.C., Houston, TX presents this very timely subject for us. Durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) includes an “entity or individual, including a physician or a Part A provider, which sells or rents Part B covered items to Medicare beneficiaries.” There are special payment rules associated with DMEPOS. DMEPOS products have to meet quality standards, DMEPOS suppliers need to be accepted by Medicare to participate (similar to providers), and are subject to fraud, waste, and abuse laws. The purpose of this webinar to provide an overview of participation and quality requirements, relay the latest compliance and requirements updates, and address False Claims Act cases involving DMEPOS companies.

Fraud & Covid-19 Webinar

Fraud, Healthcare, COVID-19, and the False Claims Act

Shauna Itri, Partner at Seeger Weiss LLP will be presenting for us today. A whistleblower or qui tam action can provide financial rewards to individuals who have information that a company/individual has committed fraud. The primary statutes under which this relief may be sought are the federal and state False Claims Acts (“FCAs”). In addition to the FCAs, there are other statutes which apply to tax fraud, securities fraud, and in California, fraud on private insurance companies. This practical Course will provide an overview of the False Claims Acts, the knowledge and skills to be able to recognize a potential whistleblower case, and understand the unique procedures utilized in filing whistleblower cases/tips. The second half of the Course will go into recent trends in cases brought (or could be brought) under the False Claims Act including cases involving mined data and potential fraud related to COVID-19.

Updated DOJ Guidance and 6 Takeaways for Compliance Officers

Updated DOJ Guidance and 6 Takeaways for Compliance Officers

On June 1, 2020, the Department of Justice’s (DOJ) Criminal Division released revisions to its Evaluation of Corporate Compliance Programs guidance for use with federal prosecutors when investigating corporations for criminal misconduct. This guidance updates the 2019 version that was covered in a previous blog post and provides insight into the DOJ’s expectations for corporate compliance programs. 

Beware of Individual Liability: Yates Memo

On September 9, 2015, the Department of Justice (DOJ) Deputy Attorney General Sally Yates released a policy memorandum, titled “Individual Accountability for Corporate Wrongdoing,” also known as the “Yates Memo.”…
Menu